Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro E R Liedke

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Lancet. Oncology|January 24, 2012
Aromatase inhibitors and musculoskeletal adverse eventsPedro E R Liedke, Paul E Goss
Critical Reviews in Oncology/Hematology|November 3, 2012
Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trialMichaela J Higgins, Pedro E R Liedke, Paul E Goss
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2013
Reply to e. Esin et alPaul E Goss, Pedro E R Liedke, Judy-Anne W Chapman, et al.
Journal of Racial and Ethnic Health Disparities|May 19, 2019
Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USAMaria Alice Franzoi, Gilberto Schwartsmann, Sérgio Jobim de Azevedo, et al.
Clinical Breast Cancer|December 18, 2013
Intermittent letrozole therapy for metastatic breast cancer: case reports and literature reviewLei Fan, Pedro E R Liedke, Steven J Isakoff, et al.
The Lancet. Oncology|August 1, 2012
Breast cancer in Mexico: a growing challenge to health and the health systemYanin Chávarri-Guerra, Cynthia Villarreal-Garza, Pedro E R Liedke, et al.
BMC Cancer|September 10, 2014
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspectiveYanin Chavarri-Guerra, Jessica St Louis, Pedro E R Liedke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2013
Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort studyPedro E R Liedke, Dianne M Finkelstein, Jackie Szymonifka, et al.
Clinical Genitourinary Cancer|February 21, 2021
Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV StudyFernando C Maluf, Fabrício A M de Oliveira, Pedro E R Liedke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trialVered Stearns, Judith-Anne W Chapman, Cynthia X Ma, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Lancet. Oncology|January 24, 2012
Aromatase inhibitors and musculoskeletal adverse eventsPedro E R Liedke, Paul E Goss
Critical Reviews in Oncology/Hematology|November 3, 2012
Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trialMichaela J Higgins, Pedro E R Liedke, Paul E Goss
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2013
Reply to e. Esin et alPaul E Goss, Pedro E R Liedke, Judy-Anne W Chapman, et al.
Journal of Racial and Ethnic Health Disparities|May 19, 2019
Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USAMaria Alice Franzoi, Gilberto Schwartsmann, Sérgio Jobim de Azevedo, et al.
Clinical Breast Cancer|December 18, 2013
Intermittent letrozole therapy for metastatic breast cancer: case reports and literature reviewLei Fan, Pedro E R Liedke, Steven J Isakoff, et al.
The Lancet. Oncology|August 1, 2012
Breast cancer in Mexico: a growing challenge to health and the health systemYanin Chávarri-Guerra, Cynthia Villarreal-Garza, Pedro E R Liedke, et al.
BMC Cancer|September 10, 2014
Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspectiveYanin Chavarri-Guerra, Jessica St Louis, Pedro E R Liedke, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2013
Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort studyPedro E R Liedke, Dianne M Finkelstein, Jackie Szymonifka, et al.
Clinical Genitourinary Cancer|February 21, 2021
Neutropenia Prevention in the Treatment of Post-docetaxel Metastatic, Castration-resistant Prostate Cancer With Cabazitaxel and Prednisone: A Multicenter, Open-label, Single-arm Phase IV StudyFernando C Maluf, Fabrício A M de Oliveira, Pedro E R Liedke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trialVered Stearns, Judith-Anne W Chapman, Cynthia X Ma, et al.
Pageof 2